BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4190097)

  • 21. [Subarachnoid hemorrhages associated with increased fibrinolysis].
    Wieczorek V; Brodkorb W; Remde W
    Munch Med Wochenschr; 1970 Jan; 112(9):366-9. PubMed ID: 5467410
    [No Abstract]   [Full Text] [Related]  

  • 22. A new assay for the measurement of total progressive antithrombin.
    Lane JL; Bird P; Rizza CR
    Br J Haematol; 1975 May; 30(1):103-15. PubMed ID: 53064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical hemorrhagic syndrome. Formulation of a practical procedure for the investigation and treatment in the absence of a specialized laboratory].
    Otteni JC; Boyer C; Girardel JM; Gauthier-Lafaye JP
    Anesth Analg (Paris); 1969; 26(3):377-92. PubMed ID: 5804825
    [No Abstract]   [Full Text] [Related]  

  • 24. [Defibrination syndrome: treatment with an antifibrinolytic drug and anticoagulants].
    Mannucci PM; Lobina G; Biggio P; Caocci L; Congiu P
    Clin Ter; 1967 Oct; 43(1):19-33. PubMed ID: 4884577
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical treatment of disseminated intravascular blood clotting].
    Michalowska R
    Pol Tyg Lek; 1969 Sep; 24(37):1418-21. PubMed ID: 4900169
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemorrhagic complications following prostatectomy].
    Anger G; Willing E
    Z Urol Nephrol; 1978 Nov; 71(11):815-20. PubMed ID: 735474
    [No Abstract]   [Full Text] [Related]  

  • 27. Inefficacy of fresh frozen plasma in the treatment of L-asparaginase-induced coagulation factor deficiencies during ALL induction therapy.
    Nowak-Göttl U; Rath B; Binder M; Hassel JU; Wolff J; Husemann S; Ritter J
    Haematologica; 1995; 80(5):451-3. PubMed ID: 8566890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amicar and hyperfibrinolysis.
    Med Lett Drugs Ther; 1967 Jan; 9(3):10-1. PubMed ID: 6067964
    [No Abstract]   [Full Text] [Related]  

  • 29. A tanned red cell hemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin-alpha1-antiplasmin complexes in human plasma.
    Collen D; De Cock F
    Thromb Res; 1975 Jul; 7(1):235-8. PubMed ID: 125465
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of antifibrinolytic agents of postirradiation blood coagulation disorders].
    Pospísil J; Skala E; Beran M; Dienstbier Z
    Cas Lek Cesk; 1967 Oct; 106(43):1164. PubMed ID: 6077103
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemostatic abnormalities in ischemic stroke].
    Misz M; Oláh L; Kappelmayer J; Blaskó G; Udvardy M; Fekete I; Csépány T; Ajzner E; Csiba L
    Orv Hetil; 1998 Oct; 139(42):2503-7. PubMed ID: 9810164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombin: mechanism of action and clinical usage. Conclusion.
    Riess H
    Blood Coagul Fibrinolysis; 1998 Nov; 9 Suppl 3():S23-4. PubMed ID: 10102496
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disorders of coagulation in gynecology and obstetrics. 1. Mechanisms of coagulation and their exploration].
    Hendeles SM; Vekemans M
    J Gynecol Obstet Biol Reprod (Paris); 1973; 2(8):1073-87. PubMed ID: 4620225
    [No Abstract]   [Full Text] [Related]  

  • 34. 2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase.
    Arnesen H; Fagerhol MK
    Scand J Clin Lab Invest; 1972 May; 29(3):259-63. PubMed ID: 4114014
    [No Abstract]   [Full Text] [Related]  

  • 35. [LIVER AND BLOOD COAGULATION. II. ANTITHROMBIN AND ANTITHROMBOPLASTIN ACTIVITY IN LIVER PATIENTS].
    SOARDI F; BOLANDRINA E
    Gazz Int Med Chir; 1964 Jan; 68():185-93. PubMed ID: 14154378
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug therapy in blood coagulation disorders].
    Markwardt F
    Zentralbl Chir; 1975; 100(22):1345-51. PubMed ID: 1202856
    [No Abstract]   [Full Text] [Related]  

  • 37. [Efficiency and limits of blood coagulation tests].
    Róka L
    Internist (Berl); 1973 Apr; 14(4):149-53. PubMed ID: 4577209
    [No Abstract]   [Full Text] [Related]  

  • 38. [On differential therapy with antifibrinolytic agents].
    Marx R; Matis P; Mayer W; Weinzierl M
    Med Welt; 1968 Apr; 17():1134-8. PubMed ID: 5303822
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of alpha2-macroglobulin and FDP on the antithrombin III assay system (author's transl)].
    Yoshida N; Tachiya K; Moroi M; Matsuda M; Aoki N
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):197-201. PubMed ID: 70144
    [No Abstract]   [Full Text] [Related]  

  • 40. [Coagulation disorders in the postpartum period. Case study].
    Krüger G
    Zentralbl Gynakol; 1967 Nov; 89(46):1687-94. PubMed ID: 5302252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.